Mpox, an infectious disease caused by the monkeypox virus, has re-emerged with new variants spreading in Central Africa, especially affecting children and adults in the Democratic Republic of the Congo.
The World Health Organization has declared the mpox virus a global health emergency twice within two years, marking its alarming spread to over 70 countries in 2022.
Mpox infections lead to painful, pus-filled skin rashes lasting up to four weeks, and while treatment options are limited, supportive care can help those with robust immune systems.
Though tecovirimat was permitted for use during the 2022 outbreak under special conditions, no specific treatments are officially approved for mpox infections.
Collection
[
|
...
]